scholarly journals Diagnosis of limbal stem cell deficiency based on corneal epithelial thickness measured on anterior segment optical coherence tomography

2017 ◽  
Vol 65 (11) ◽  
pp. 1120 ◽  
Author(s):  
MaheshChandra Agarwal ◽  
Amit Mehtani ◽  
Sushant Sharma ◽  
Santosh Chaudhary
Keyword(s):  
Optical Coherence Tomography ◽  
Stem Cell ◽  
Anterior Segment ◽  
Limbal Stem Cell Deficiency ◽  
Optical Coherence ◽  
Corneal Epithelial ◽  
Epithelial Thickness ◽  
Corneal Epithelial Thickness ◽  
Limbal Stem Cell

Evaluation of corneal epithelial thickness in glaucomatous patients using anterior‐segment optical coherence tomography

2019 ◽  
Vol 13 (1) ◽  
Author(s):  
Daniela Montorio ◽  
Gilda Cennamo ◽  
Maria A. Breve ◽  
Ugo Fiore ◽  
Michele Reibaldi ◽  
...  
Keyword(s):  
Optical Coherence Tomography ◽  
Anterior Segment ◽  
Optical Coherence ◽  
Corneal Epithelial ◽  
Epithelial Thickness ◽  
Corneal Epithelial Thickness

scholarly journals High-Resolution Optical Coherence Tomography Angiography Characteristics of Limbal Stem Cell Deficiency

Diagnostics ◽  
2021 ◽  
Vol 11 (6) ◽  
pp. 1130
Author(s):  
Shobhit Varma ◽  
Swapna S. Shanbhag ◽  
Pragnya Rao Donthineni ◽  
Dilip Kumar Mishra ◽  
Vivek Singh ◽  
...  
Keyword(s):  
Optical Coherence Tomography ◽  
Stem Cell ◽  
High Resolution ◽  
Imaging Modality ◽  
Multiple Logistic Regression Analysis ◽  
Anterior Segment ◽  
Limbal Stem Cell Deficiency ◽  
Vascular Density ◽  
Optical Coherence ◽  
Limbal Stem Cell

This study aimed to identify the anterior segment high-resolution optical coherence tomography (HR-OCT) and HR-OCT angiography (HR-OCTA) features suggestive of limbal stem cell deficiency (LSCD) as confirmed by both impression cytology (IC) and in vivo confocal microscopy (IVCM). This was a single-centre prospective cross-sectional study including 24 eyes of 22 patients with clinical suspicion of LSCD based on peripheral superficial corneal vascularisation and scarring. On IC and IVCM, performed and interpreted by blinded observers, 12 eyes each were diagnosed with and without LSCD. Additionally, 10 eyes of 5 healthy volunteers with no ocular pathology were also imaged. The 136 HR-OCT/A images of these 34 eyes were analysed with respect to 12 imaging parameters; the parameters most suggestive of LSCD were identified and the sensitivity and specificity were calculated. In the LSCD group, the most common aetiology was ocular chemical burns (83%), whereas in the non-LSCD group, the most common aetiology was viral keratitis (67%). Multiple logistic regression analysis revealed that mean epithelial reflectivity, mean stromal reflectivity, and mean superficial vascular density were the parameters that were diagnostic of LSCD on HR-OCT/A (p < 0.0001). A ratio of the mean epithelial reflectivity to stromal reflectivity of >1.29 corresponded with a high sensitivity (91.7%) and specificity (98.75%); while a mean superficial vascular density score of >0.38 corresponded with a sensitivity of 97.9% and specificity of 73.8%. In conclusion, HR-OCT/A as a non-invasive imaging modality could prove to be a useful tool for confirming the diagnosis of LSCD, with potential clinical and research applications.

Effects of topical antiglaucomatous medications on central corneal epithelial thickness by anterior segment optical coherence tomography

2020 ◽  
Vol 30 (6) ◽  
pp. 1519-1524
Author(s):  
Emine Doğan ◽  
Burçin Köklü Çakır ◽  
Nilgün Özkan Aksoy ◽  
Erkan Celik ◽  
Ünal Erkorkmaz
Keyword(s):  
Optical Coherence Tomography ◽  
Central Corneal Thickness ◽  
Corneal Thickness ◽  
Anterior Segment ◽  
Tear Film ◽  
Optical Coherence ◽  
Corneal Epithelial ◽  
Duration Of Therapy ◽  
Epithelial Thickness ◽  
Corneal Epithelial Thickness

Purpose: To evaluate the effect of topical antiglaucomatous medications on central corneal epithelial thickness measured by anterior segment optical coherence tomography. Materials and methods: A total of 153 eyes of 153 patients using topical antiglaucomatous medications and 110 eyes of 110 control subjects were enrolled. Glaucoma type, duration of therapy, the number of drugs, and drops/day were noted in the patient group. Patients and control subjects underwent ocular examinations including Schirmer test, slit lamp examination for tear film break-up time, and anterior segment optical coherence tomography for central corneal thickness and central corneal epithelial thickness. Central corneal epithelial thickness and other data were evaluated separately with regard to glaucoma type, duration of therapy, the number of drops, and drugs in the patient group. Results: The mean ages of the patients and controls were 60.1 ± 10.8 and 58.7 ± 11.2 years, respectively. The groups were similar with regard to mean age and gender (p = 0.058, p = 0.734, respectively). The median (interquartile range) central corneal thickness was 536 (54) µm in patients and 552 (53) µm in controls (p = 0.011). The median (interquartile range) central corneal epithelial thickness of patients and controls were 56 (4) µm and 60 (8) µm, respectively (p < 0.001). The median (interquartile range) tear film break-up time and Schirmer were 12 (6) s and 10 (8) mm in patients and 16 (2) s and 18 (4) mm in controls, respectively (p < 0.001, p < 0.001). In patient group, there was no significant difference in the median central corneal thickness, central corneal epithelial thickness, and tear film break-up time in terms of glaucoma type, duration of therapy, the number of drugs, and the number of daily drops. Only the median Schirmer test was found to be statistically lower in terms of number of daily eye drops (p = 0.039). Conclusion: Using topical antiglaucomatous medications seems to affect the central corneal epithelial thickness in glaucoma patients. Central corneal epithelial thickness was thinner in glaucoma patients than controls. Anterior segment optical coherence tomography might be helpful to evaluate the effect of antiglaucomatous medications on central corneal epithelial thickness during treatment.

Sign in / Sign up

Export Citation Format

Share Document